Biomarkers of PUFA and cardiovascular risk factors and events in healthy Asian populations: a systematic review.

The associations between circulating PUFA and cardiovascular risk factors and events in healthy Asian populations have been less examined robustly compared with Western populations. This systematic review aimed to summarise current evidence on the associations between -3 and -6 PUFA biomarkers and cardiovascular risk factors and events in healthy Asian populations. Four databases were searched for observational studies from 2010 until 2024. Twenty-three studies were eligible, which covered six Asian countries and included events ( 7), traditional risk factors such as blood pressure and lipids ( 4), physical signs such as arterial stiffness ( 4), non-traditional lipid markers ( 1), markers of inflammation ( 4), markers of thrombosis ( 2) and non-invasive imaging-based markers ( 5). Biological sample types included plasma ( 6), serum ( 14) and erythrocyte ( 3). Higher circulating total -3 PUFA appeared to be associated with lower hypertension risk and specifically EPA and DHA to be associated with lower myocardial infarction risk, reduction in TAG and inflammation. Higher circulating linoleic acid was associated with improved lipid profiles and lower inflammation. Limited evidence led to inconclusive associations between circulating -6 PUFA biomarkers and CVD events and blood pressure. No consistent associations with arterial stiffness, obesity, thrombosis and imaging-based biomarkers were observed for circulating PUFA biomarkers in Asian populations. Limited studies exist for each outcome; hence, results should be interpreted with caution. More high-quality and prospective studies in Asian populations are warranted. Several recommendations such as sample size justification and reporting of non-respondents rate are proposed for future studies.